(IMAGE)

Centro Nacional de Investigaciones Oncológicas (CNIO)

Caption

Luis Álvarez-Vallina, head of CNIO’s H12O-CNIO Cancer Immunotherapy Clinical Research Unit an senior author of the study.

 

Credit

Laura M. Lombardía/CNIO

Usage Restrictions

Only to be used in the context of this press release.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.